cat |
LD50 |
subcutaneous |
> 10mg/kg (10mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. |
dog |
LD50 |
subcutaneous |
> 40mg/kg (40mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. |
monkey |
LD50 |
subcutaneous |
> 20mg/kg (20mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. |
mouse |
LD50 |
intravenous |
66mg/kg (66mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 188, 1972. |
mouse |
LD50 |
oral |
490mg/kg (490mg/kg) |
BEHAVIORAL: TOXIC PSYCHOSIS |
Pharmacology: International Journal of Experimental and Clinical Pharmacology. Vol. 15, Pg. 485, 1977. |
mouse |
LD50 |
subcutaneous |
160mg/kg (160mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 188, 1972. |
rat |
LD50 |
intravenous |
48mg/kg (48mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 188, 1972. |
rat |
LD50 |
oral |
160mg/kg (160mg/kg) |
|
Acta Neurologia et Psychiatrica Belgica. Vol. 61, Pg. 611, 1961. |
rat |
LD50 |
subcutaneous |
160mg/kg (160mg/kg) |
|
Acta Neurologia et Psychiatrica Belgica. Vol. 61, Pg. 611, 1961. |